Connection
Nicholas Cost to Doxorubicin
This is a "connection" page, showing publications Nicholas Cost has written about Doxorubicin.
|
|
Connection Strength |
|
 |
|
 |
|
1.287 |
|
|
|
-
Hecht SL, Quach A, Gao D, Brazell A, Beltran G, Holbrook S, Gore L, Iguchi N, Malykhina A, Wilcox D, Cost NG. A prospective survey study of lower urinary tract dysfunction in childhood cancer survivors after vincristine and/or doxorubicin chemotherapy. Pediatr Blood Cancer. 2021 10; 68(10):e29226.
Score: 0.692
-
Iguchi N, D?nmez MI, Carrasco A, Wilcox DT, Pineda RH, Malykhina AP, Cost NG. Doxorubicin induces detrusor smooth muscle impairments through myosin dysregulation, leading to a risk of lower urinary tract dysfunction. Am J Physiol Renal Physiol. 2019 07 01; 317(1):F197-F206.
Score: 0.595